Oisin Biotechnologies
http://www.oisinbio.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Oisin Biotechnologies
Finance Watch: VC Mega-Rounds Ease Into Summer Slowdown
Private Company Edition: Venture capital investment has moved into a slower summer pace, or maybe just shifted to small- and medium-sized biopharma financings. In addition to Third Arc’s $165m series A round, Brenig raised a $65m series A and Confo’s series B totaled €60m ($65m).
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice